An aflatoxin-associated mutational hotspot at codon 249 in the p53 tumor suppressor gene occurs in hepatocellular carcinomas from Mexico

Carcinogenesis

Volumn 17, Issue 5, 1996, Pages 1007-1012

  Soini, Y ^a,b   Chia, S C ^c   Bennett, W P ^a   Groopman, J D ^d   Wang, J S ^d   DeBenedetti, V M G ^a   Cawley, H ^a   Welsh, J A ^a   Hansen, C ^a   Bergasa, N V ^a   Jones, E A ^a   DiBisceglie, A M ^a   Trivers, G E ^a   Sandoval, C A ^e   Calderon, I E ^e   Munoz Espinosa, L E ^e   Harris, C C ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF OULU   (Finland)

^c CHANGI GENERAL HOSPITAL   (Singapore)

^d JOHNS HOPKINS UNIVERSITY   (United States)

^e HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

[No Author keywords available]

Indexed keywords

AFLATOXIN B1; DNA; HEPATITIS ANTIBODY; PROTEIN P53; RABBIT ANTISERUM; SERUM ALBUMIN;

ADULT; AGED; ARTICLE; CARCINOGEN DNA INTERACTION; CLINICAL ARTICLE; DNA ADDUCT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATITIS B; HEPATITIS C; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CELL CARCINOMA; MALE; MEXICO; MISSENSE MUTATION; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; TUMOR SUPPRESSOR GENE;

ADULT; AFLATOXIN B1; AGED; ANIMALS; BASE SEQUENCE; CARCINOGENS; CARCINOMA, HEPATOCELLULAR; CODON; FEMALE; GENES, P53; HEPATITIS B; HEPATITIS C; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; RABBITS; SERUM ALBUMIN;

EID: 15844415447     PISSN: 01433334     EISSN: None     Source Type: Journal    
DOI: 10.1093/carcin/17.5.1007     Document Type: Article

References (52)

1. Hollstein,M., Sidransky,D., Vogelstein,B. and Harris,C.C. (1991) p53 mutations in human cancer. Science, 253, 49-53.
2. Greenblatt,M.S., Bennett,W.P., Hollstein,M. and Harris,C.C. (1994) Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 55, 4855-4878.
3. Lane,D.P. (1992) p53, guardian of the genome. Nature, 358, 15-16.
4. Yonish-Rouach,E., Resnitzky,D., Lotem,J., Sachs,L., Kimchi,A. and Oren,M. (1991) Wild-type p53 induces apoptosis of myeloid leukaemic cells that is inhibited by interleukin-6. Nature, 352, 345-347.
5. Wands,J.R. and Blum,H.E. (1991) Primary hepatocellular carcinoma. New Engl. J. Med., 325, 729-731.
6. Ross,R.K., Yu,M.C., Henderson,B.E., Yuan,J.M., Qian,G.S., Tu,J.T., Gao,Y.T., Wogan,G.N. and Groopman,J.D. (1992) Afiatoxin biomarkers. Lancet, 340, 119.
7. Ross,R.K., Yuan,J.M., Yu,M.C., Wogan,G.N., Qian,G.S., Tu,J.T., Groopman,J.D., Gao,Y.T. and Henderson,B.E. (1992) Urinary aflatoxin biomarkers and risk of hepatocellular carcinoma. Lancet, 339, 943-946.
8. Qian,G.S., Ross,R.K., Yu,M.C., Yuan,J.M., Gao,Y.T., Henderson,B.E., Wogan,G.N. and Groopman,J.D. (1994) A follow-up study of urinary markers of aflatoxin exposure and liver cancer risk in Shanghai. People's Republic of China. Cancer Epidemiol. Biomarkers. Prev., 3, 3-10.
9. Aguilar,F., Hussain,S.P and Cerutti,P. (1993) Aflatoxin B1 induces the transversion of G to T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc. Natl Acad. Sci. USA. 90, S586-S590.
10. Hulla,J.E., Chen,Z.Y. and Eaton,D.L. (1993) Aflatoxin B1-induced rat hepatic hyperplastic nodules do not exhibit a site-specific mutation within the p53 gene. Cancer Res., 53, 9-11.
11. Lilleberg,S.L., Cabonce,M.A., Raju,N.R., Wagner,L.M. and Kier,L.D. (1992) Alterations in the p53 tumor suppressor gene in rat liver tumors induced by aflatoxin B1. Prog. Clin. Biol. Res., 376, 203-222.
12. Fujimoto,Y., Hampton,L.L., Luo,L.D., Wirth,P.J. and Thorgeirsson,S.S. (1992) Low frequency of p53 gene mutation in tumors induced by aflatoxin B1 in nonhuman primates. Cancer Res., 52, 1044-1046.
13. Hsu,I.C., Metcalf,R.A., Sun,T. Welsh,J.A., Wang,N.J. and Harris,C.C. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature, 350, 427-428.
14. Bressac,B., Kew,M., Wands,J. and Ozturk,M. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 350, 429-431.
15. Ozturk,M. and Collaborators,A. (1991) p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet. 338, 1356-1359.
16. Aguilar,F., Harris,C.C., Sun,T., Hollstein,M. and Cerutti,P. (1994) Geographic variation of p53 mutational profile in nonmalignant human liver. Science, 264, 1317-1319.
17. Cho,Y., Gorina,S., Jeffrey,P. and Pavletich,N.P. (1994) Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations. Science, 364, 346-355.
18. Harris,C.C. (1994) Solving the viral-chemical puzzle of human liver carcinogenesis. Cancer Epidemiol. Biomarkers Prev., 3, 1-2.
19. Rogler,C.E. and Chisari,F.V. (1992) Cellular and molecular mechanisms of hepatocarcinogenesis. Semin. Liver Dis., 12, 265-278.
20. Feitelson,M.A., Zhu,M., Duan,L.-X. and London,W.T. (1993) Hepatitis B x antigen and p53 are associated in vitro and in liver tissues from patients with primary hepatocellular carcinoma. Oncogene. 8, 1109-1117.
21. Wang,X.W., Forrester,K., Yeh,H., Feitelson,M.A., Gu,J.-R. and Harris,C.C. (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA bindins, transcriptional activity, and association with transcription factor ERCC3. Proc. Natl Acad. Sci. USA, 91, 2230-2234.
22. Ueda,H., Ullrich,S.J., Gangemi,J.D., Kappel,C.A., Ngo,L., Feitelson,M.A. and Jay,G. (1995) Functional inactivation but not structural mutation of p53 causes liver cancer. Nature Genet., 9, 41-47.
23. Benn,J. and Schneider, R.J. (1994) Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras. Raf. MAP kinase signaling cascade. Proc. Natl Acad. Sci. USA, 91, 10350-10354.
24. Bennett,W.P. et al. (1993) p53 protein accumulates frequently in early bronchial neoplasia. Cancer Res., 53, 4817-4822.
25. Sanger,F., Nicklen,S. and Coulson,A.R. (1977) DNA sequencing with chain-terminating inhibitors. Proc. Natl Acad. Sci. USA, 74, 5463-5467.
26. Wang,E.H., Friedman,P.N. and Prives,C. (1989) The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen. Cell, 57, 379-392.
27. Midgley,C.A., Fisher,C.J., Bartek,J., Vojtesek,B., Lane,D.P. and Barnes,D.M. (1992) Expression of human p53 in bacteria: application to the analysis of p53 expression in human tumours. J. Cell Sci., 101, 183-189.
28. Hill,P.G. and Wells,T.N. (1983) Bromocresol purple and the measurement of albumin. Falsely high plasma albumin concentrations eliminated by increased reagent ionic strength. Ann. Clin. Biochem., 20, 264-270.
29. Bradford,M.M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem,. 72, 248-254.
30. Sheabar,F.Z., Groopman,J.D., Qian,G.S. and Wogan,G.N. (1993) Quantitative analysis of aflatoxin-albumin adducts. Carcinogenesis, 14, 1203-1208.
31. Groopman,J.D., Trudel,L.J., Donahue,P.R., Marshak-Rothstein,A. and Wogan,G.N. (1984) High-affinity monoclonal antibodies for aflatoxins and their application to solid-phase immunoassays. Proc. Natl Acad. Sci. USA, 81, 7728-7731.
32. Gange,S.J., Munoz,A., Wang,J. and Groopman,J.D. (1996) Variability of molecular biomarker measurements from nonlinear calibration curves. Cancer Epidemiol. Biomarkers Prev., 4. in press.
33. Sabbioni,G., Ambs,S., Wogan,G.N. and Groopman,J.D. (1990) The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples. Carcinogenesis. 11. 2063-2066.
34. Sabbioni,G., Skipper,P.L., Buchi,G. and Tannenbaum,S.R. (1987) Isolation and characterization of the major serum albumin adduct formed by aflatoxin B1 in vivo in rats. Carcinogenesis, 8, 819-824.
35. Garcia-Compean,D., Guzman-de la Garza,F.J. and Munoz-Espinosa,L.E. (1994) Cancer hepatico primario. Caracteristicas epidemiologicas, clinicas y bioquimicas. Rev. Gastroenterol. Mex., 59, 17-22.
36. Carvajal,M. (1992) Control program of aflatoxins of corn in Mexico. In Proceedings of the VIII International IUPAC Symposium on Mycotoxins and Phycotoxins. International Union of Pure and Applied Chemistry. Mexico, pp. 31-34.
37. Torres,E., Nacha,L.R., Acuna,K., Montoya,J.R. and Castrellon,J.P. (1992) Quantifications of aflatoxins in corn distributed in the city of Monterrey, N.L. In Proceedings of VIII International IUPAC Symposium on Mycotoxins and Phycotoxins. International Union of Pure and Applied Chemistry. Mexico, pp. 128.
38. Coursaget,P., Depril,N., Chabaud,M., Nandi,R., Mayelo,V., LeCann,P. and Yvonnet.B. (1993) High prevalence of mutations at codon 249 of the p53 gene in hepatocellular carcinomas from Senegal. Br. J. Cancer, 67, 1395-1397.
39. Sheu,J.C. et al. (1992) Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res., 52, 6098-6100.
40. Hollstein,M.C., Wild,C.P., Bleicher,F., Chutimataewin,S., Harris,C.C., Srivatanakul,P. and Montesano,R. (1993) p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand. Int. J. Cancer, 53, 51-55.
41. Hosono,S., Chou,M.J., Lee,C.S. and Shih,C. (1993) Infrequent mutation of p53 gene in hepatitis B virus positive primary hepatocellular carcinomas. Oncogene, 8, 491-496.
42. Debuire,B., Paterlini,P., Pontisso,P., Basso,G. and May,E. (1993) Analysis of the p53 gene in European hepatocellular carcinomas and hepatoblastomas. Oncogene, 8, 2303-2306.
43. Hall,A.J. and Wild,C.P. (1994) In Eaton,D.L. and Groopman,J.D. (eds), The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. Academic Press, New York, NY, pp. 233-258.
44. Liu,Y.H., Taylor,J., Linko,P., Lucier,G.W. and Thompson,C.L. (1991) Glutathione S-transferase mu in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis, 12, 2269-2275.
45. McGlynn,K.A. et al. (1995) Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc. Natl Acad. Sci. USA, 92, 2384-2387.
46. Wild,C.P., Jansen,L.A., Cova,L. and Montesano,R. (1993) Molecular dosimetry of aflatoxin exposure: contribution to understanding the multifactorial etiopathogenesis of primary hepatocellular carcinoma with particular reference to hepatitis B virus. Environ. Hlth Perspect., 99, 115-122.
47. Wang,J.-S. et al. (1996) Temporal patterns of aflatoxin-albumin adducts in hepatitis B surface antigen positive and negative residents of Daxin. Qidong County, P.R.C. Cancer Epidemiol. Biomarkers Prev., 5, in press.
48. Phillips,T., Clement,B.A. and Park,D.L. (1994) In Eaton,D.L. and Groopman,J.D. (eds), The Toxicology of Aflatoxins: Human Health, Veterinary and Agricultural Significance. Academic Press, New York, NY, pp. 383-408.
49. Herrera,F., Juarez-Figureoa,L., Piedras,J. and Mendez,J. (1990) Seroprevalencia de marcadores de los virus de hepatitis C (VHC) y B (VHB) en donadores de sangre familiares. Rev. Gastroenterol. Mex., 54, 312.
50. Lobato-Mendizaval,E., Marin-Lopez,A. and Labastida-Munoz,H. (1984) Prevalencia del antigeno de superficie del virus B de la hepatitis (AgsVBH) en una poblacion hospitalaria. Rev. Gastroenterol. Mex., 49, 303.
51. Kershenobich,D. et al. (1990) Seroprevalence of viral markers of hepatitis B among health professionals. Multicenter study in Mexico. Rev. Invest. Clin., 42, 251-256.
52. Melendez,N., Sifuentes-Osornio,J., Diaz,L., Guadarrama,E., Chayez,B., Hernandez,L., Hurtado,R. and Lisker-Melman,M. (1993) Prevalencia de marcadores de hepatitis en la poblacion de donadores del Instituto Nacional de la Nutricion Salvador Zubiran (1991-1993). Rev. Gastroenterol. Mex., 58, 326.